Immunology
Showing page 76 of 176 pages of list content
-
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters
This article's authors -
Neutralization Of SARS-CoV-2 Variants By A Human Polyclonal Antibody Therapeutic (COVID-HIG, NP-028) With High Neutralizing Titers To SARS-CoV-2
This article's authors -
Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release
This article's authors -
Omicron BA.2 specifically evades broad sarbecovirus neutralizing antibodies
This article's authors -
Circulatory exosomes from COVID-19 patients trigger NLRP3 inflammasome in endothelial cells
This article's authors -
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron
This article's authors -
Development and optimisation of a high-throughput screening assay for in vitro anti–SARS-CoV-2 activity: evaluation of 5676 phase 1 passed structures
This article's authors -
CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation
This article's authors -
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine
This article's authors -
Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-CoV-2 viruses
This article's authors